No Data
No Data
Teleflex to Present at the BofA Securities 2025 Health Care Conference
The FDA Has Granted 510(k) Clearance Of An Expansion To The Indications For Use Of Teleflex's QuikClot Control+ Hemostatic Device To Include All Grades Of Internal And External Bleeding
Teleflex Receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+ Hemostatic Device
Express News | Teleflex Receives FDA 510(K) Clearance for Expanded Indications of the Quikclot Control+™ Hemostatic Device
Earnings Preview: Teleflex to Report Financial Results Pre-market on May 01
Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting